Antibodies
15 March 2016
FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer11 March 2016
ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-402 in CD-19 Positive B-cell Non-Hodgkin Lymphomas10 March 2016
New Data from Largest Prospective Study on CroFab® for Treatment of Copperhead Snake Envenomation10 March 2016
Cantargia AB’s CAN04 Product Candidate Shows Good Safety after Repeated Doses in New Toxicity Study8 March 2016
Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA8 March 2016
Xencor Initiates Two Phase 2 Trials of XmAb5871 in IgG4-Related Disease and Systemic Lupus Erythematosus3 March 2016
Formycon discloses details on second pipeline product – FYB203 is a biosimilar for Eylea® (aflibercept)2 March 2016
Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologic in EU Clinical Trial29 February 2016
AstraZeneca reports top-line result of tremelimumab monotherapy trial in mesothelioma29 February 2016
Genentech Provides Update on Two Identical Phase III Studies of Lebrikizumab in People with Severe AsthmaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports